Investigational new drug TAP-1502 beginning clinical study for seborrheic dermatitis

1. Seborrheic dermatitis (SD) is a common chronic inflammatory skin condition characterized by erythema, pruritus, and scaling [1]. SD is present in regions rich in sebaceous glands, such as the sc...

Authors

Sanat Subhash (ORCID: https://orcid.org/0009-0008-9477-5136)
S FELDMAN
Burhan A. Buttar

Institutions

Wake Forest University (US)

Publication Details

Journal: Expert Opinion on Investigational Drugs
Published: 2026-07-01
DOI: https://doi.org/10.1080/13543784.2026.2698521
Primary Topic: Nail Diseases and Treatments
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Investigational new drug TAP-1502 beginning clinical study for seborrheic dermatitis

Sanat Subhash, S FELDMAN, Burhan A. Buttar

Jul 1, 2026

Expert Opinion on Investigational Drugs

Nail Diseases and Treatments

article

Investigational new drug TAP-1502 beginning clinical study for seborrheic dermatitis

Sanat Subhash, S FELDMAN, Burhan A. Buttar

July 1, 2026article en

Abstract

Expert Opinion on Investigational Drugs

Wake Forest University (US)

Good health and well-being

Openalex Percentile: Top 7%

Nail Diseases and Treatments

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Investigational new drug TAP-1502 beginning clinical study for seborrheic dermatitis — Sanat Subhash, S FELDMAN, et al. · Expert Opinion on Investigational Drugs (2026) | TGRS Research Map | TGRS